1. Home
  2. TECX vs PFL Comparison

TECX vs PFL Comparison

Compare TECX & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$19.63

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Logo PIMCO Income Strategy Fund Shares of Beneficial Interest

PFL

PIMCO Income Strategy Fund Shares of Beneficial Interest

HOLD

Current Price

$8.39

Market Cap

374.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
PFL
Founded
2019
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
359.0M
374.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
PFL
Price
$19.63
$8.39
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$81.20
N/A
AVG Volume (30 Days)
350.0K
113.7K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
11.53%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$6.98
52 Week High
$61.07
$8.62

Technical Indicators

Market Signals
Indicator
TECX
PFL
Relative Strength Index (RSI) 52.23 45.08
Support Level $17.79 $8.37
Resistance Level $19.12 $8.42
Average True Range (ATR) 1.43 0.04
MACD -0.22 -0.01
Stochastic Oscillator 48.25 15.79

Price Performance

Historical Comparison
TECX
PFL

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest

PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.

Share on Social Networks: